Clinical Trials

Nov
11

Remdesivir Shows Promise in Largest of Several Clinical Trials

Remdesivir is a drug produced by Gilead Sciences for helping in treating Ebola patients. This antiviral drug has even experimented in the US clinical trials on around 1,063 coronavirus patients. When a patient suffering from the dreaded COVID-19 disease is hospitalized, he/she takes an average of 15 odd days to completely recover. When the same […]

DETAIL
Jun
29

Could Statins Reduce the Severity of COVID-19?

The recent data about the huge growth rate of COVID-19 shows that blood clots, intense inflammation, and stroke are some of the severe symptoms that are caused by coronavirus disease. Years of research also shows that apart from lowering the cholesterol levels, statins also play a big role in reducing blood clots, decreasing inflammation, and […]

DETAIL